Pfizer (NYSE:PFE) surged about 3% on Tuesday morning after the drugmaker posted first-quarter results that beat Wall Street's forecasts, driven by aggressive expense reductions. Adjusted earnings per ...

Pfizer maintained its 2025 guidance but noted it does not include any impact of tariffs or trade policy, “which we are unable to predict at this time.” ...

Pfizer expanded its cost-cutting plans and posted first-quarter profit above estimates, despite a decline in sales driven by ...

The company forecast 2025 sales of between $61 billion and $64 billion ... but also currently trending toward the upper end of its adjusted earnings outlook for the year. Pfizer generated record ...

Pfizer’s first-quarter revenue missed analyst estimates as it faces an “uncertain and volatile external environment.” ...

Pfizer reaffirmed its 2025 outlook of $61 to $64 billion in revenue and adjusted earnings per share of $2.80 to $3. StockStory aims to help individual investors beat the market.

Pfizer on Tuesday expanded its cost-cutting efforts and reported first-quarter profit that topped ... Pfizer did not revise its outlook. The company maintained its full-year 2025 outlook ...